SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Dec 20, 2007
Insider Transaction Report
Form 4
Lamm Robert
SVP, Quality & Reg. Affairs
Transactions
- Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-19$4.67/sh+4,433$20,702→ 46,851 total - Sale
Common Stock, $.01 par value per share
2007-12-19$20.75/sh−4,433$91,984→ 42,418 total - Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-19$2.97/sh+567$1,684→ 42,985 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-19$4.67/sh−4,433$20,702→ 567 totalExercise: $4.67From: 2003-06-10Exp: 2012-06-10→ Common Stock, $.01 par value per share (4,433 underlying) - Sale
Common Stock, $.01 par value per share
2007-12-19$20.75/sh−567$11,765→ 42,418 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-19$2.97/sh−567$1,684→ 26,433 totalExercise: $2.97From: 2004-01-22Exp: 2013-01-22→ Common Stock, $.01 par value per share (567 underlying)
Footnotes (1)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.